Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
Healthcare prices have increased over the past year, and typically care prices and overall health spending outpace growth in the rest of the economy.
Cancer care has become the top driver of large employers' health care costs due to an increase in late-stage diagnoses, according to a new survey from the Business Group on Health.
The online retail giant revealed plans last week to shutter Amazon Care, its in-house business providing virtual and in-person medical services. The business launched in 2019 as a pilot project and then quickly expanded its telehealth services to all 50 states
For the second quarter in a row, the insurance industry saw the largest year-over-year growth in digital fraud attempts with an increase of 159% from Q2 2021 to Q2 2022, according to TransUnion’s latest quarterly fraud analysis report.
Telehealth, also known as virtual health care, offers patients the opportunity to see a doctor from almost anywhere if the patient and doctor have access to an online connection. It can be done on a laptop or desktop computer, tablet, or smartphone. Small business group health insurance plans have offered covered employees and family members ...
Virtual health is here to stay following a massive increase in use during the pandemic, but employers believe that it needs to evolve, a new survey shows. Nearly three-quarters (74%) of the 135 large employers surveyed this summer by the Business Group on Health said virtual care will have a major impact on care delivery in the ...
A new study by the Employee Benefit Research Institute (EBRI) found that workers with employer-sponsored health insurance are paying an increasing share of their health care costs. This is driven, primarily, by the growth of the High Deductible Health Plans (HDHPs).
The median annual price of 13 new drugs approved this year by the U.S. Food and Drug Administration for chronic conditions is $257,000, according to a new analysis from Reuters. Additionally, seven other recently launched drugs are priced at more than $200,000 per year.
Some of the biggest hospital chains are seeing business rebound to pre-pandemic levels, but the industry as a whole is pressing for more federal relief before year’s end, citing inflation, labor and supply cost pressures. Why it matters: Hospitals are the biggest driver of U.S. health care spending, and the pandemic has tested Washington’s willingness to take on ...
The Biden administration is investing $98.9 million in grant funding to 59 returning Navigator organizations that assist consumers in picking an Affordable Care Act (ACA) exchange plan.